Nonprofit does not mean free, or financially undisciplined.
The polyclinic earns recurring clinical income. Outreach, navigation and professional exchange are financed through cross-subsidy, donations, restricted grants and programme partnerships.
Indicative start-up capital
BWP 9.0-20.5m
Fit-out, clinical and digital equipment, outreach vehicles, licensing, launch stock, working capital and contingency.
Annual operating cost at stabilisation
BWP 9.3-19.1m
Driven by people, clinical scope, facilities, supplies, outreach frequency and quality systems.
Planning assumptions, not supplier quotations or an investment offer. They require validation through property, equipment, staffing, payer and route studies.
Earned income
Patient fees, medical-aid payments, selected employer contracts and approved training income.
Philanthropic income
Botswana and German giving, foundations, corporate sponsorship and restricted programme grants.
European funding
Competitive calls and consortium opportunities once governance, track record and reporting capacity are established.
Reserve objective
At least four months of unrestricted operating expenditure after stabilisation.
What mission-aligned capital can fund
- Feasibility, licensing and institutional formation
- Maun facility fit-out and maintainable clinical equipment
- Outreach vehicles, field diagnostics and secure digital systems
- Patient navigation, social work and transport support
- Specialist exchange, local training and reciprocal placements
- Monitoring, external audit and independent evaluation
Expansion follows clinical safety, reliable funding and demonstrated outcomes.
Feasibility
0-6 months
Formation
6-12 months
Controlled launch
12-18 months
Stabilisation
18-36 months
Evidence-led expansion
36-60 months
90%
Reliable access
of planned outreach visits completed after the pilot year
95%
Continuity
of actionable results communicated and documented
90%
Patient experience
reporting respect, privacy and understanding
4 mo.
Financial resilience
of unrestricted operating expenditure held in reserve
Targets remain provisional until local baseline data, route selection and the first operating year are complete. Melapo will publish an annual impact and accountability report including unmet targets and corrective actions. Clinical safety, completed care pathways and capability transfer are also tracked.